Plant exosomes non-coding RNA-mediated anti-inflammatory mechanisms

植物外泌体非编码RNA介导的抗炎机制

基本信息

  • 批准号:
    9036506
  • 负责人:
  • 金额:
    $ 47.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-12-01 至 2020-11-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The overall goal of this proposal is to define the role of edible plant exosomal non-coding small RNA (nc-sRNA) in the prevention of gut inflammation using the dextran sulfate sodium (DSS) induced colitis and three other gut inflammatory related mouse models. Although evidence is supportive of the beneficial effects for most edible plants taken as part of the diet, the evidence that specific plant-based supplements are beneficial is controversial, and the underlying mechanisms are not clear. The challenge is to isolate and characterize the biological activities of the essential functional unit contained in specific naturl products to determine if and how it's cellular and molecular effects on the host can be used in a beneficial manner. Our recently published data (1-5) indicates that exosome-like nanoparticles (ELNs) present in a number of edible plants including grapefruit and ginger have anti-inflammatory properties. Mice fed grapefruit ELNs (FELNs) are protected against DSS induced mouse colitis. Up take of FELNs by intestinal macrophages inhibits the release of IL-1β and IL-6 and the induction of HO-1 and IL-10 expression. Our preliminary data further indicate that FELNs carry high levels of specific nc-sRNA that inhibit the induction of proinflammatory cytokines by targeting intestinal macrophages. The nc-sRNA is associated with inactivation of macrophage miR155. A specific FELN nc-sRNA complexed with naringin binds to miR155 and subsequently prevents miR155 binding to 3-UTRs of certain anti-inflammatory genes, thus inhibiting the induction of proinflammatory cytokines. We have also demonstrated that ginger ELN nc-sRNAs promotes the production of IL-10 in lamina propria macrophages under steady-state as well as inflammatory conditions. Therefore, we hypothesize that plant ELNs carrying the nc-sRNA bioactive complex are taken up by intestinal macrophages and subsequently bind to inflammatory microRNAs, resulting in inhibition of induction of chronic inflammation cytokines, thereby preventing chronic intestinal inflammation. Our hypothesis will be tested in vitro and in vivo to determine: (1) whether FELN taken up by intestinal macrophages leads to induction of tolerant dendritic cells (DCs) through nc-sRNA-155 mediated anti-inflammatory effects since DCs are critical for gut immune tolerance and homeostasis through cross-talk with intestinal macrophages; (2) the factors that regulate sorting of anti-inflammatory nc-sRNA-155 into macrophage exosomes; and (3) which ginger ELNs nc-sRNA(s) are required for induction of anti- inflammatory IL-10 expressed in macrophages. Demonstration of the ELNs complex targeting to gut inflammatory cells would be a significant step forward in the understanding of how the plant kingdom interacts with the mammalian species to regulate anti-inflammatory responses through ELNs. The data generated should provide a foundation for selecting specific ELNs from different types of plants for personalized complementary medicine for patients and determine whether oral administration of a customized exosome isolated from different plants will have a synergistic/additive effect on prevention or treatment of disease.
 描述(由申请人提供):该提案的总体目标是确定可食用植物外泌体非编码小RNA(nc-sRNA)在预防肠道炎症中的作用,使用葡聚糖硫酸钠(DSS)诱导的结肠炎和三种其他肠道炎症相关的小鼠模型虽然证据支持大多数可食用植物作为饮食的一部分具有有益作用,但特定植物性补充剂有益的证据存在争议,而且其潜在机制尚不明确。明确的挑战是分离和表征特定天然产品中所含基本功能单元的生物活性,以确定是否以及如何以有益的方式利用它对宿主的细胞和分子影响(1-。 5)表明,存在于包括葡萄柚和生姜在内的多种可食用植物中的外泌体样纳米粒子(ELN)具有抗炎特性,喂食葡萄柚 ELN(FELN)的小鼠可以免受 DSS 诱导的小鼠结肠炎的影响。肠道巨噬细胞对 FELN 的抑制可抑制 IL-1β 和 IL-6 的释放以及 HO-1 和 IL-10 表达的诱导。我们的初步数据进一步表明,FELN 携带高水平的特异性 nc-sRNA,可抑制促炎的诱导。 nc-sRNA 与巨噬细胞 miR155 的失活相关,与柚皮苷复合的特定 FELN nc-sRNA。 miR155,并随后阻止 miR155 与某些抗炎基因的 3-UTR 结合,从而抑制促炎细胞因子的诱导。我们还证明,生姜 ELN nc-sRNA 在稳态下促进固有层巨噬细胞中 IL-10 的产生。因此,我们合作携带 nc-sRNA 生物活性复合物的植物 ELN 被肠道巨噬细胞吸收,随后与炎症结合。 microRNA,从而抑制慢性炎症细胞因子的诱导,从而预防慢性肠道炎症。我们的假设将在体外和体内进行测试,以确定:(1)肠道巨噬细胞吸收的 FELN 是否会导致诱导耐受的树突状细胞(DC)。 )通过 nc-sRNA-155 介导的抗炎作用,因为树突状细胞通过与肠道巨噬细胞的相互作用对肠道免疫耐受和稳态至关重要;(2)调节抗炎分选的因素; nc-sRNA-155 进入巨噬细胞外泌体;以及 (3) 哪些生姜 ELN nc-sRNA 是诱导巨噬细胞中表达的抗炎 IL-10 所必需的。在了解植物界如何与哺乳动物物种相互作用以通过 ELN 调节抗炎反应方面迈出了重要的一步。生成的数据将为从中选择特定的 ELN 提供基础。不同类型的植物为患者提供个性化补充医学,并确定口服从不同植物中分离的定制外泌体是否会对疾病的预防或治疗产生协同/相加作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HUANG-GE ZHANG其他文献

HUANG-GE ZHANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HUANG-GE ZHANG', 18)}}的其他基金

RA synovial fibroblast exosomes(RA-EXo) mediated bone erosion via AhR/TRAF2pathway
RA滑膜成纤维细胞外泌体(RA-EXo)通过AhR/TRAF2通路介导骨侵蚀
  • 批准号:
    10622327
  • 财政年份:
    2022
  • 资助金额:
    $ 47.3万
  • 项目类别:
BLR&D Research Career Scientist Award application
BLR
  • 批准号:
    9899084
  • 财政年份:
    2018
  • 资助金额:
    $ 47.3万
  • 项目类别:
BLR&D Research Career Scientist Award application
BLR
  • 批准号:
    10454206
  • 财政年份:
    2018
  • 资助金额:
    $ 47.3万
  • 项目类别:
BLR&D Research Career Scientist Award application
BLR
  • 批准号:
    10265394
  • 财政年份:
    2018
  • 资助金额:
    $ 47.3万
  • 项目类别:
Mechanisms underlying edible exosome-like nanoparticles for prevention of brain inflammation
可食用外泌体样纳米颗粒预防脑部炎症的机制
  • 批准号:
    10668525
  • 财政年份:
    2015
  • 资助金额:
    $ 47.3万
  • 项目类别:
Mechanisms underlying edible exosome-like nanoparticles for prevention of brain inflammation
可食用外泌体样纳米颗粒预防脑部炎症的机制
  • 批准号:
    10517568
  • 财政年份:
    2015
  • 资助金额:
    $ 47.3万
  • 项目类别:
Exosomal TRAF2-CSN5 complex mediated inflammation promotes tumor growth
外泌体TRAF2-CSN5复合物介导的炎症促进肿瘤生长
  • 批准号:
    8212755
  • 财政年份:
    2011
  • 资助金额:
    $ 47.3万
  • 项目类别:
Exosomal TRAF2-CSN5 complex mediated inflammation promotes tumor growth
外泌体TRAF2-CSN5复合物介导的炎症促进肿瘤生长
  • 批准号:
    8696800
  • 财政年份:
    2011
  • 资助金额:
    $ 47.3万
  • 项目类别:
Exosomal TRAF2-CSN5 complex mediated inflammation promotes tumor growth
外泌体TRAF2-CSN5复合物介导的炎症促进肿瘤生长
  • 批准号:
    8044373
  • 财政年份:
    2011
  • 资助金额:
    $ 47.3万
  • 项目类别:
Exosomal TRAF2-CSN5 complex mediated inflammation promotes tumor growth
外泌体TRAF2-CSN5复合物介导的炎症促进肿瘤生长
  • 批准号:
    8398935
  • 财政年份:
    2011
  • 资助金额:
    $ 47.3万
  • 项目类别:

相似国自然基金

“消炎良境”铂药纳米制剂增强免疫治疗转移性结直肠癌的研究
  • 批准号:
    82073398
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
面向水中非甾体类消炎药选择性吸附光催化分解的金属有机框架的设计与机理研究
  • 批准号:
    21906007
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
  • 批准号:
    10556857
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
  • 项目类别:
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
  • 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
  • 项目类别:
Cellular and Metabolic Dysfunction in Sepsis-Induced Immune Paralysis
脓毒症引起的免疫麻痹中的细胞和代谢功能障碍
  • 批准号:
    10724018
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
  • 项目类别:
Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
异常免疫球蛋白糖基化导致急性莱姆病感染期间的免疫调节
  • 批准号:
    10726417
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了